# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-25-021513
Filing Date
2025-11-10
Accepted
2025-11-10 16:11:41
Documents
19
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 35694
2 | EX-99.1 | ex99-1.htm | EX-99.1 | 176437
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 194381
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 196275
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 94775
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 33047
7 | GRAPHIC | ex99-1_05.jpg | GRAPHIC | 1518650
| Complete submission text file | 0001493152-25-021513.txt |  | 3206997

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | imdx-20251110.xsd | EX-101.SCH | 3011
9 | XBRL LABEL FILE | imdx-20251110_lab.xml | EX-101.LAB | 34239
10 | XBRL PRESENTATION FILE | imdx-20251110_pre.xml | EX-101.PRE | 22356
22 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3692

Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 251466311
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)